(415) 353-9888 (appts)
(415) 353-9959 (fax)

Box 1705, UCSF; San Francisco, CA 94143-1705

additional websites:

UCSF Physician Referral Directory
Faculty Profile

Rutgers College, New Brunswick, New Jersey, BA, 1976, Biological Sciences
University of California San Francisco, MD, 1980, Medicine
University of California San Francisco, Internship, 1981, Internal Medicine
University of California, Davis, Residency, 1985, Internal Medicine
University of California San Francisco, Fellowship, 1987, Hematology/Oncology

Venook AP and Warren RS: Regional chemotherapy approaches for primary and metastatic liver tumors. Surg Onc Clin No Amer 5:411-427,1996.

Venook AP, Goodnight J, Kumar S, Taylor C, Gilden R, Figlin RA: Practice guidelines for colorectal cancer. Cancer J Sci Am 2 (supplement): S23-S36, 1996.

Venook AP, Goodnight J, Smith NG, Taylor C, Gilden R, Figlin RA: Practice guidelines for gastric cancer. Cancer J Sci Am 2 (supplement): S45-S52, 1996.

Goodnight J, Venook AP, Ames M, Taylor C, Gilden R, Figlin RA: Practice guidelines for esophageal cancer. Cancer J Sci Am 2 (supplement): S37-S43, 1996.

Goodnight J, Venook AP, Fringer J, Taylor C, Gilden R, Figlin RA: Practice guidelines for pancreatic cancer. Cancer J Sci Am 2 (supplement): S53-S60, 1996.

Venook AP, Eaton V, Chang J, Frey J, Ring E, Stagg RJ: Chemoembolization for liver metastases from uveal melanoma. GI Cancer 1: 269-273, 1996.

Dorsey BV, Benjamin LE, Rauscher F, Klencke B, Venook AP, Warren RS, Weidner N: Intra-abdominal desmoplastic small round-cell tumor: expansion of the pathologic profile. Mod Pathol 9: 703-709, 1996.

Kirn D, Venook AP, Penn I: Pulmonary aspergillosis masquerading as progressive post-transplant lymphoma. Transpl Int 9: 517-519, 1996.

Venook AP: Can a vitamin prevent hepatocellular carcinoma? Hepatology 22: 249-250, 1997.

Venook AP: Update on hepatic intra-arterial chemotherapy. Oncology 11: 947-957, 1997.

Venook AP: Treatment of hepatocellular carcinoma: a review of selected significant papers since 1995. Medscape Oncology 1 (12), 1997.

Venook AP, Egorin MJ, Rosner GL, Brown TD, Jahan TM, Batist G, Hohl R, Budman D, Ratain MJ, Kearns CM, Schilsky RL: A phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: CALGB 9264. J Clin Oncol 16: 1811-1819, 1998.

Floren LC, Hebert MF, Venook AP, Jordan VC, Cisneros A, Somberg KA: Tamoxifen in liver disease: potential exacerbation of hepatic dysfunction. Ann Oncol 9: 1123-1126, 1998.

Venook AP: Embolization and chemoembolization therapy for neuroendocrine tumors. Current Opinion in Oncology 11: 38-41, 1999.

Rubin J, Ajani J, Schirmer W, Venook AP, Bukowski R, Pommier R, Saltz L, Dandona P, Anthony L: Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. J Clin Oncol 17: 600-606, 1999.

Venook AP, Egorin MJ, Rosner GL, Brown TD, Jahan TM, Batist G, Hohl R, Budman D, Ratain MJ, Kearns CM, Schilsky RL: Trial of Paclitaxel in Patients with Hepatic Dysfunction; Cancer and Leukemia Group B 9264. J Clin Oncol-Classic Papers and Current Comments 4;1: 185-194, 1999.

Bloom AI, Gordon RL, Ahl KH, Kerlan RK Jr, LaBerger JM, Wilson MW, Venook AP, Warren RS: Transcatheter embolization for the treatment of misperfusion after hepatic artery chemoinfusion pump implantation. Ann Surg Onc 6(4): 350-358.

Venook AP: Regional strategies for managing hepatocellular carcinoma. Oncology 14(3): 347-354, 2000.

Venook AP, Egorin MJ, Rosner GL, Holis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ: A phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: CALGB 9565. J Clin Oncolo 18: 2780-2787, 2000.

Bergsland EK, Venook AP: hepatocellular carcinoma. Curr Opin Oncol 12: 357-361, 2000.

Venook AP: Hepatocellular Carcinoma. Curr Treatment Options in Oncol 1:407-414, 2000.

Venook AP, Warren RS: Therapeutic approaches to metastasis confined to the liver. Curr Oncol Rep 3: 109-115, 2001.

Yao FY Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook AP, Ascher NL, Roberts JP: Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Soize Limits Does Not Adversely Impact Survival. Hepatology 33(6): 1394-1403, 2001.

12/15/04